[Clinical study of L-dopa in Parkinson's disease].
D000203:Activities of Daily Living; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008124:Locomotion; D008297:Male; D008875:Middle Aged; D009048:Motor Skills; D009069:Movement Disorders / Q000139:chemically induced; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D026741:Physical Therapy Modalities; D013997:Time Factors
D004295:Dihydroxyphenylalanine
Contribution à l'étude clinique de la L-dopa dans la maladie de Parkinson.